eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on May 29, 2024. The filing discloses significant changes in executive leadership, specifically the resignation of the Chief Financial Officer (CFO) and the appointment of a successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and transition arrangements.
Material Changes
- Resignation of CFO: John Stelben notified the Company of his resignation as Senior Vice President and CFO, effective August 30, 2024. The resignation is not due to any disagreement regarding operations, policies, or practices.
- Appointment of New CFO: John Dolan, currently Senior Vice President and Chief Accounting Officer, will succeed Mr. Stelben as Senior Vice President and CFO, effective August 31, 2024. Mr. Dolan will also serve as the Principal Financial and Accounting Officer.
- Transition Arrangement: Mr. Stelben will serve as a consultant from approximately September 1, 2024, to December 31, 2024, receiving a monthly fee of $10,000. He will receive no severance payments and will not vest in equity following his resignation.
Compensation and Outlook
Mr. Dolan's new compensation package includes:
- Base Salary: $440,000 annually.
- Cash Bonus: Eligibility for a discretionary incentive bonus with a target of 75% of base salary (prorated for 2024).
- Equity Awards:
- 48,750 time-based Restricted Stock Units (RSUs) vesting annually over three years.
- 26,250 performance-based RSUs tied to adjusted EBITDA margin goals over a two-year period, with vesting contingent on a one-year service requirement post-performance period.
- Severance: Under a standard agreement, termination "without cause" or resignation for "good reason" entitles Mr. Dolan to 12 months of base salary and 12 months of health benefits. In the event of a change of control within one year, he would also receive 100% of his target bonus and full vesting of time-based equity.
The filing includes a press release issued on May 30, 2024, regarding these changes. No specific financial guidance or outlook was provided in this document.
Investor Verification Checklist
- Verify the exact effective dates of the CFO transition (August 30/31, 2024) and the interim consulting period.
- Review the upcoming Form 10-Q for the quarter ended June 30, 2024, for the full text of the Consulting Agreement with Mr. Stelben.
- Monitor future filings for the executed Severance Agreement and Indemnification Agreement for Mr. Dolan.
- Assess the impact of the leadership change on the Company's ability to meet the adjusted EBITDA margin goals tied to Mr. Dolan's performance-based equity.